The best indicator for Baker Hughes (BKR)
We backtested 20 indicators across daily, weekly and hourly charts on real Baker Hughes (BKR) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
WaveTrend (8/6/4)
On the weekly chart, this is the strongest risk-adjusted edge we found for Baker Hughes (BKR) over ~39.3 years — trailing buy-and-hold by 0.2% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | WaveTrend (8/6/4) ✓ | Weekly | 5.9% | 0.35 | -65.9% | 74.2% | 31 | -0.2% |
| 2 | Stochastic ✓ | Weekly | 5.8% | 0.34 | -59.9% | 70.0% | 40 | -0.4% |
| 3 | MACD ✓ | Weekly | 4.8% | 0.31 | -69.3% | 48.2% | 83 | -1.3% |
| 4 | Rate of Change ✓ | Weekly | 4.6% | 0.3 | -57.0% | 43.2% | 125 | -1.6% |
| 5 | Money Flow Index ✓ | Daily | 4.0% | 0.28 | -68.5% | 69.4% | 36 | -2.1% |
| 6 | CCI ✓ | Weekly | 3.6% | 0.27 | -63.8% | 75.7% | 37 | -2.5% |
| 7 | EMA 50/200 Cross ✓ | Daily | 2.6% | 0.23 | -65.3% | 35.5% | 31 | -3.5% |
| 8 | Stochastic ✓ | Daily | 2.4% | 0.23 | -74.4% | 65.0% | 206 | -3.7% |
| 9 | Donchian Midline ✓ | Weekly | 2.7% | 0.23 | -74.1% | 40.9% | 110 | -3.5% |
| 10 | EMA 20/50 Cross ✓ | Daily | 2.4% | 0.22 | -60.8% | 38.4% | 99 | -3.7% |
| 11 | RSI Mean-Reversion ✓ | Weekly | 3.8% | 0.33 | -32.1% | 90.0% | 10 | -2.4% |
| 12 | ADX / DMI | Weekly | 2.5% | 0.22 | -61.4% | 40.0% | 50 | -3.6% |
| 13 | Holy Grail Confluence ✓ | Weekly | 3.3% | 0.25 | -60.1% | 69.2% | 13 | -2.8% |
| 14 | Money Flow Index ✓ | Weekly | 4.8% | 0.32 | -69.7% | 70.0% | 10 | -1.3% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Baker Hughes (BKR), WaveTrend (8/6/4) on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.